butyrate glp-1 Sodium reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression Butyrate binds to free fatty

A prolonged treatment experiment spanning 3 weeks further substantiated these findings

Phase II data showed weight loss of up to approximately 20% at 52 weeks, with monthly dosing that could offer meaningful convenience advantages over weekly injections

Endocrinology, 152 , 33623372

In a study involving patients with CAD and preserved LV function, who were scheduled to undergo coronary artery bypass grafting (CABG), were randomized to receive standard therapy or treatment with GLP-1 (1.5 pmol/kg/min) as a continuous infusion beginning 12 h before CABG and continuing for 48 h after the procedure

However, she felt she lost too much weight and didn't want to continue the medication